MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution, covering 2009-09-23 to 2009-09-23. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia [Phase 4]